FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/12/038972 [Registered on: 28/12/2021] Trial Registered Prospectively
Last Modified On: 27/12/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic
Screening 
Study Design  Other 
Public Title of Study   Effect of Prapunnadadi cream in the treatment of Ekakushtha 
Scientific Title of Study   Comparative clinical study on the efficacy of Prapunnadadi Cream and Panchatikta Ghrita Verses Atrisor Cream and Panchatikta Ghrita in the management of Ekakushtha Psoriasis 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Swapnil Bhoyar 
Designation  pg scholar 
Affiliation  datta meghe institute of medical science 
Address  room no 30 department of Kayachikitsa Mahatma gandhi ayurved college hospital and research center salod wardha
room no 30 department of Kayachikitsa Mahatma gandhi ayurved college hospital and research center salod wardha
Wardha
MAHARASHTRA
442001
India 
Phone  8668841496  
Fax    
Email  swapnilbhoyar1809@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sourabh Deshmukh 
Designation  Associate Professor 
Affiliation  datta meghe institute of medical sciences 
Address  Room No 30 Department of Kayachikitsa Mahatma gandhi ayurved college hospital and research center
Room no 30Department of Kayachikitsa Mahatma gandhi ayurved college hospital and research center
Wardha
MAHARASHTRA
442001
India 
Phone  9404337799  
Fax    
Email  ayurrulz@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sourabh Deshmukh 
Designation  Associate Professor 
Affiliation  datta meghe institute of medical sciences 
Address  Room no 30 Department of Kayachikitsa Mahatma gandhi ayurved college hospital and research center
Room no 30 Department of Kayachikitsa Mahatma gandhi ayurved college hospital and research center
Wardha
MAHARASHTRA
442001
India 
Phone  9404337799  
Fax    
Email  ayurrulz@gmail.com  
 
Source of Monetary or Material Support  
Mahatma gandhi ayurved college hospital and research center salod wardha 
 
Primary Sponsor  
Name  Mahatma gandhi ayurved college hospital and research center 
Address  room no 30 department of Kayachikitsa Mahatma gandhi ayurved college hospital and research center salod wardha 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Swapnil Bhoyar  Mahatma gandhi ayurved college hospital and research center  Room no 30 Department of kayachikitsa Mahatma gandhi ayurved college hospital and research center
Wardha
MAHARASHTRA 
8668841496

swapnilbhoyar1809@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Mahatma gandhi ayurved college hospital and research center institutional ethics committee salod wardha  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L400||Psoriasis vulgaris. Ayurveda Condition: EKAKUSHTHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: prapunnadadi cream, Reference: charak samhita, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 1(NA), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: internally panchtikta ghrita 5ml twice daily
2Comparator ArmDrugOther than Classical(1) Medicine Name: Atrisor cream, Reference: NA, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 1(NA), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: internally panchtikta ghrita 5 ml twice daily
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Subjects Having Cardinal features ok Ekakushtha
Aswedanam
Mahavastu
Matsyashaklopamam
Kandu
Mild to Moderate Psoriasis according to PASI Scale 
 
ExclusionCriteria 
Details  Diagnosed diseases like Diabetes Mellitus Cancer AIDS and Tuberculosis
Subject of other dermatological infectious conditions
Pregnant or lactating women
Severe Psoriasis Cases according to PASI Scale
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess the efficacy of Prapunnadadi cream and Panchatikta ghrita on absent sweating, spread over large area of body, fishy scales, itching  4 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
To assess the efficacy of Prapunnadadi cream and panchatikta ghrita on pasi scale in Ekakushtha  4 weeks 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   22/02/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The volunteers will be informed about the study protocol. Willing participants will be randomly selected as per computerized generated table. Clinical research format will be prepared and validated. Prior to the study approval will be taken from IEC, MGACHRC, Salod (H) Wardha and CTRI registration will be done.After selection, each participant will be tested individually and selected according to selection criteria. They are divided into two groups.The trial is a parallel-group, randomized, open label, standard - controlled trial. It will include, a 30 days treatment period, and a 0th, 15th 30th day follow-up period. 
Close